e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
O'Donnell D.E., Fluge T., Gerken F., Hamilton A., Webb K., Aguilaniu B., Make B., Magnussen H.
Source:
Eur Respir J 2004; 23: 832-840
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O'Donnell D.E., Fluge T., Gerken F., Hamilton A., Webb K., Aguilaniu B., Make B., Magnussen H.. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-840
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 86-94
Year: 2004
Exercise and dyspnoea in COPD
Source: Eur Respir Rev 2006; 15: 72-79
Year: 2006
Lung hyperinflation in COPD: the impact of pharmacotherapy
Source: Eur Respir Rev 2006; 15: 85-89
Year: 2006
Heliox, dyspnoea and exercise in COPD
Source: Eur Respir Rev 2009; 19: 30-38
Year: 2010
Dyspnoea
Source: Respipedia Article
Year: 2016
Lung hyperinflation, dyspnoe, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD
Source: Eur Respir J 2004; 24: 385-390
Year: 2004
Physiology and consequences of lung hyperinflation in COPD
Source: Eur Respir Rev 2006; 15: 61-67
Year: 2006
Tiotropium as essential maintenance therapy in COPD
Source: Eur Respir Rev 2006; 15: 51-57
Year: 2006
Evaluation of bronchodilator responses in patients with "irreversible" emphysema
Source: Eur Respir J 2001; 18: 914-920
Year: 2001
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 217-224
Year: 2002
Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 639-644
Year: 2002
Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Mechanisms limiting exercise in COPD: new insights
Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease
Year: 2005
NIV and pulmonary rehabilitation
Source: Eur Respir Mon; 2008: 41: 265–271
Year: 2008
Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance
Source: Eur Respir Rev 2006; 15: 37-41
Year: 2006
Bronchodilator responsiveness in patients with COPD
Source: Eur Respir J 2008; 31: 742-750
Year: 2008
New strategies to improve exercise capacity in COPD
Source: Annual Congress 2006 - MP1 – New strategies to improve exercise capacity in COPD
Year: 2006
Enhanced cytokine response to exercise in COPD
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
Impact of exercise training on quality of life in patients with end-stage emphysema
Source: Annual Congress 2006 - Contemporary management of patients with end-stage emphysema
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept